Understand neutropenia diagnosis, clinical documentation, and medical coding. Find information on absolute neutrophil count ANC, severe congenital neutropenia SCN, cyclic neutropenia, drug-induced neutropenia, and ICD-10 codes for neutropenia. Learn about neutropenia treatment, management, and the role of healthcare professionals in diagnosing and documenting this condition. Explore resources for accurate medical coding and billing related to neutropenia.
Also known as
Neutropenia
Abnormally low levels of neutrophils in the blood.
Other white blood cell disorders
Includes other specified white blood cell disorders, not elsewhere classified.
Other specified abnormal findings
Can be used for neutropenia if documented as present but no other code applies.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is neutropenia congenital?
Yes
Is it severe congenital neutropenia?
No
Is it drug-induced?
When to use each related code
| Description |
|---|
| Low neutrophil count |
| Febrile neutropenia |
| Chronic neutropenia |
Coding D70 without specifying severity or cause leads to inaccurate risk adjustment and reimbursement.
Failing to code adverse drug reactions causing neutropenia (e.g., using D70 instead of a T45 code) impacts patient safety data.
Incorrectly differentiating between neutropenia (D70) and agranulocytosis (D70.0) affects severity reporting and treatment choices.
Q: What are the most effective evidence-based management strategies for chemotherapy-induced neutropenia in adult cancer patients?
A: Chemotherapy-induced neutropenia (CIN) is a common and serious side effect of cancer treatment. Effective management of CIN involves a multi-pronged approach, including primary prophylaxis with granulocyte colony-stimulating factors (G-CSFs) in patients at high risk (e.g., intensive chemotherapy regimens, older age, pre-existing neutropenia). Consider implementing prophylactic antibiotics in patients with prolonged neutropenia or other risk factors for infection. Supportive care measures, like meticulous hygiene and prompt treatment of febrile neutropenia, are crucial. Explore how dose adjustments or treatment delays might minimize neutropenia without compromising cancer treatment efficacy. The latest clinical guidelines, such as those from the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO), provide detailed recommendations on CIN management based on patient-specific factors and risk stratification. Learn more about personalized CIN management strategies based on recent clinical trial data.
Q: How can I differentiate between benign chronic neutropenia and more serious forms of neutropenia in the primary care setting?
A: Distinguishing benign chronic neutropenia, like mild congenital neutropenia or ethnic neutropenia, from more concerning neutropenias involves a thorough evaluation. Start with a detailed medical history, including family history of blood disorders, infections, medications, and ethnicity. A complete blood count (CBC) with differential is essential to quantify the absolute neutrophil count (ANC). If the ANC is mildly to moderately low and the patient is asymptomatic or has a history of mild, infrequent infections, benign chronic neutropenia is likely. However, consider implementing further investigations, such as bone marrow examination, genetic testing, or immunological studies, if the neutropenia is severe, progressive, or associated with recurrent or severe infections, splenomegaly, or other concerning symptoms. These investigations can help identify underlying causes like cyclic neutropenia, severe congenital neutropenia (Kostmann syndrome), or autoimmune neutropenia. Explore the diagnostic algorithms for neutropenia to guide your decision-making.
Patient presents with signs and symptoms suggestive of neutropenia, including fatigue, weakness, fever, chills, and recurrent infections. The patient reports a history of [insert relevant past medical history, e.g., recent chemotherapy, viral infection, autoimmune disorder, or exposure to certain medications]. Physical examination reveals [insert relevant physical exam findings, e.g., pallor, oral ulcers, tachycardia, or signs of infection]. Complete blood count (CBC) with differential demonstrates absolute neutrophil count (ANC) of [insert ANC value], confirming the diagnosis of neutropenia. Severity of neutropenia is classified as [mild, moderate, or severe] based on the ANC. Differential diagnosis includes [list potential differential diagnoses, e.g., aplastic anemia, leukemia, myelodysplastic syndrome, vitamin B12 deficiency, or drug-induced neutropenia]. Further investigations, such as bone marrow biopsy, peripheral blood smear review, and serological testing for infections, may be indicated to determine the underlying etiology of the neutropenia. Treatment plan includes [mention treatment strategies such as granulocyte colony-stimulating factor (G-CSF) administration, prophylactic antibiotics, and management of underlying conditions]. Patient education provided on infection prevention strategies, including hand hygiene, avoidance of sick contacts, and prompt reporting of fever. Follow-up CBC scheduled to monitor neutrophil recovery. ICD-10 code D70. Medical billing codes will be dependent on the specific procedures performed and the complexity of the evaluation and management.